Microfluidic Technology Expands Effectiveness of Medical Treatment of Organs and Organ Systems

Finnadvance

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Advances in microfluidic technology further open up opportunities for pharma R&D teams to conduct human-like clinical trials for drug development.

The technology extends further into hospitals for clinical diagnostic testing to help physicians prescribe the most effective treatment. A major application of microfluidics in clinical studies includes the development of organ-on-a-chip solutions that mimic non-performing systems in the body to activate the correct responses.

Finnish startup Finnadvance manufactures multi-channel 3D microfluidic organ-on-a-chip systems that simulate the activities, mechanics, and physiological response of entire organs and organ systems.